Literature DB >> 4158023

rheumatoid factors in primary and reactive macroglobulinaemia.

F Klein, P Mattern.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 4158023      PMCID: PMC1031010          DOI: 10.1136/ard.24.5.458

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  18 in total

1.  IMMUNOLOGICAL RELATIONSHIPS BETWEEN AFRICAN TRYPANOSOMES AND THEIR HOSTS.

Authors:  B WEITZ
Journal:  Ann N Y Acad Sci       Date:  1963-12-30       Impact factor: 5.691

2.  Rheumatoid factor, complement, and conglutinin aberrations in patients with subacute bacterial endocarditis.

Authors:  R C WILLIAMS; H G KUNKEL
Journal:  J Clin Invest       Date:  1962-03       Impact factor: 14.808

3.  Comparative studies of serologic tests for rheumatoid disease. I. A comparison of a latex test and two erythrocyte agglutination tests in a random population sample.

Authors:  J BALL; R DE GRAAFF; H A VALKENBURG; F W BOERMA
Journal:  Arthritis Rheum       Date:  1962-02

4.  The relationship of the latex fixation test to the clinical and serologic manifestations of leprosy.

Authors:  E S CATHCART; R C WILLIAMS; H ROSS; E CALKINS
Journal:  Am J Med       Date:  1961-11       Impact factor: 4.965

5.  Destruction of some agglutinins but not of others by two sulfhydryl compounds.

Authors:  R GRUBB; B SWAHN
Journal:  Acta Pathol Microbiol Scand       Date:  1958

6.  [New aspects of splenomegaly in African Negroes; splenomegalic syndrome with macroglobulinemia].

Authors:  G CHARMOT; J DEMARCHI; J ORIO; R REYNAUD; R VARGUES
Journal:  Presse Med       Date:  1959-01-03       Impact factor: 1.228

7.  Studies on the rheumatoid and related serum factors. I. Autoimmunization of rabbits with gamma globulin.

Authors:  F MILGROM; E WITEBSKY
Journal:  JAMA       Date:  1960-09-03       Impact factor: 56.272

8.  Cold agglutinin disease. A type of primary macroglobulinemia: a new concept.

Authors:  S E RITZMANN; W C LEVIN
Journal:  Tex Rep Biol Med       Date:  1962

9.  [High beta2-macroglobulinorachia in patients with African trypanosomiasis].

Authors:  P MATTERN
Journal:  Ann Inst Pasteur (Paris)       Date:  1962-01

10.  The induction of a rheumatoid factor-like substance in rabbits.

Authors:  J L ABRUZZO; C L CHRISTIAN
Journal:  J Exp Med       Date:  1961-11-01       Impact factor: 14.307

View more
  8 in total

1.  Rheumatoid arthritis in a rural South African Negro population.

Authors:  P Beighton; L Solomon; H A Valkenburg
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

2.  Polyarthritis in Western Nigeria. I. Rheumatoid arthritis.

Authors:  B M Greenwood
Journal:  Ann Rheum Dis       Date:  1969-09       Impact factor: 19.103

3.  Heterophile antibodies, M-antiglobulins and immunoglobulins in experimental trypanosomiasis.

Authors:  V Houba; K N Brown; A C Allison
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

4.  Anti-immunoglobulins and heterophil agglutinins in experimental trypanosomiasis.

Authors:  P Mattern; F Klein; R Pautrizel; Y E Jongepier-Geerdes
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

5.  Immunoglobulin studies in serum of patients with American trypanosomiasis (Chagas' disease).

Authors:  R Lelchuk; A P Dalmasso; C L Inglesini; M Alvarez; J A Cerisola
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

6.  Experimental induction of rheumatoid factor-like substances in animal trypanosomiasis.

Authors:  F Klein; P Mattern
Journal:  Clin Exp Immunol       Date:  1970-12       Impact factor: 4.330

7.  Rheumatoid arthritis in Kenya. II. Serological observations.

Authors:  V Houba; L R Bagg; D P Hansen; T Bowry
Journal:  Ann Rheum Dis       Date:  1979-02       Impact factor: 19.103

8.  Immuno-epidemiology of malaria: a study in a tribal area of West Irian.

Authors:  H J van der Kaay; F Klein; M Hagenaar-de Weerdt; J H Meuwissen
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.